Table 1 The scores of TTK expression in normal ovary and ovarian tumor
From: TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
Age | Stage | IHC Scoring | P-value | ||||
|---|---|---|---|---|---|---|---|
Negative expression (0) | Weak expression (2–4) | Moderate expression (5–6) | Strong expression (7–8) | ||||
Normal ovary (n = 20) | 39–79 | / | 20 | / | / | / | P < 0.0001 |
Ovarian tumor (n = 20) | 34–66 | IIIC-IV | / | 7 | 11 | 2 | |